Trial Profile
An Open, Prospective, Blinded Evaluation, International, Multicentre, Controlled Study of Safety and Efficacy of Thrombectomy and Standard Stroke Care in Clinical Routine Treatment of Acute Occlusive Stroke Compared to Standard Stroke Care Only
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms SITS Open
- 10 Feb 2021 Primary endpoint (Categorical shift in modified Rankin Scale score at 3 months) has been met according to Results published in the Stroke.
- 10 Feb 2021 Status changed from recruiting to completed.
- 10 Feb 2021 Results published in the Stroke